Image credit: SWITCH FB
Two new national-level consortia have been launched in Singapore to promote research, commercialisation and training in cybersecurity and synthetic biology.
The Singapore Cybersecurity Consortium (SGCSC) and the Singapore Consortium for Synthetic Biology (SINERGY) will be hosted at the National University of Singapore (NUS), and supported by the National Research Foundation (NRF) Singapore.
They were announced by Teo Chee Hean, Deputy Prime Minister, Coordinating Minister for National Security, and Chairman of NRF Singapore, at the opening of the inaugural Singapore Week of Innovation & TeCHnology (SWITCH) on 20 September 2016.
The two new consortia will encourage use-inspired research, technology translation, manpower training, and technology awareness in cybersecurity and synthetic biology. This will be done by actively promoting research discussions across industry, government agencies and researchers.
"These consortia will foster closer interaction between industry and research institutions and provide companies access to top researchers and emerging technologies," said George Loh, Director (Programmes), NRF Singapore. "[They] will result in more innovation and commercialisation in the cybersecurity and synthetic biology sectors when companies adopt the new technologies developed by the research institutions."
Singapore Cybersecurity Consortium (SGCSC)
Singapore is highly reliant on software and information technology infrastructure. Thus, cybersecurity threats pose significant challenges to the information security industry.
Led by Professor Abhik Roychoudhury from NUS School of Computing, SGCSC will promote greater awareness, adoption and translation of cybersecurity technologies.
"The consortium seeks to bridge the gap between state-of-the-practice and state-of-the-art cutting edge research in the area of cybersecurity, as well as in other areas which can benefit from advances in cybersecurity, such as the software sector and financial technologies (FinTech)," said Roychoudhury.
"[SGCSC] hopes to lower the entry barrier for the adoption of relevant technologies by companies in Singapore, and at the same time create a vibrant community of professionals who will generate novel ideas and technologies that will advance the field of cybersecurity in ways that will benefit Singapore and beyond," Roychoudhury added.
Singapore Consortium for Synthetic Biology (SINERGY)
Synthetic biology is an emerging area of research, an interdisciplinary branch of technology and engineering. Recent research has demonstrated promising application of synthetic biology in areas such as energy, healthcare, and environment.
SINERGY will be led by Associate Professor Matthew Chang, Director for the Synthetic Biology for Clinical Technological Innovation (SynCTI) programme at NUS. The new consortium will tap on the facilities and expertise at SynCTI.
"SINERGY aims to consolidate Singapore's capabilities in synthetic biology and harness synergies across industry sectors to create a vibrant and globally-connected bio-based economy in Singapore," Chang said. "[It] will contribute towards augmenting manpower development and deployment for the new bio-economy, as well as catalysing the translation of expertise in synthetic biology for industry applications."
Sign up for CIO Asia eNewsletters.